FREE ONLINE SEMINAR:
ADVANCED TECHNOLOGIES FOR SCALABLE AAV VECTOR PRODUCTION
BY DR. NICOLE FAUST, CEO
Learn about the latest developments in using stable producer cell lines for AAV manufacturing and how the ELEVECTA® system enables a fully scalable and robust vector production process without plasmid transfection or helper viruses.
Cell & Gene Therapy Manufacturing & Commercialization Digital Week – May 3, 2022